Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Neuropeptide
90%
Psoriasis
90%
Leaner Mutant Mouse
90%
Blood-Brain Barrier
90%
Diacerein
90%
Peptidoleukotriene
90%
Amino Acid
45%
Rhesus C Antibody
45%
Paraformaldehyde
45%
Toxicity
45%
Cytokine
19%
Dermatitis
19%
Sequestosome 1
11%
Proteasome
11%
Ubiquitin
11%
Binding Protein
11%
Splenomegaly
9%
Inflammation
9%
Antiinflammatory Agent
9%
C57BL 6 Mouse
9%
Neovascularization (Pathology)
9%
Imiquimod-Induced Psoriasis
9%
Neuroscience
C-Fos
90%
Neuropeptide
90%
Cysteinyl Leukotriene Receptor 1
90%
Galanin Receptor 2
90%
Galanin Receptor 3
90%
Adipose Tissue
36%
Blood Brain Barrier
36%
Behavior (Neuroscience)
36%
Feeding Behavior
18%
Immediate Early Gene
18%
Rhesus C Antibody
18%
Hypothalamus
18%
Amino Acid
18%
Alternative Splicing
18%
Staining Technique
18%
Social Behavior
18%
Habituation
18%
Immunofluorescence
18%
Social Interaction
18%
Elevated Plus Maze
12%
Ubiquitin
11%
Protein Binding
11%
Peptidoleukotriene
11%
Sequestosome 1
11%
Microvessel
11%
Cell Stress
11%
Promoter Region
11%
Galanin
6%
Water Maze
6%
Medicine and Dentistry
Glaucoma
90%
Drug Therapy
90%
Open Angle Glaucoma
90%
Cataract Surgery
90%
Trabeculectomy
90%
Cell Activity
90%
Peptidoleukotriene
90%
Implant
45%
Cataract
45%
Hazard Ratio
45%
Protein Binding
11%
Retinal Protein
11%
Ubiquitin
11%
Cellular Senescence
11%
Microvessel
11%
Proteasome
11%
Sequestosome 1
11%
